Syneos Health Reports Fourth Quarter and Full Year 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/28/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- First Financial to acquire Hickory Point Bank in $111.3M deal
- McKesson reports cybersecurity incident affecting its information systems
- Affirm Holdings (AFRM) Tops Q4 EPS by $3.77, Beats on Revenue
- Nasdaq, S&P 500 lifted by Nvidia's forecast; investors eye speech by Fed's Warsh
- BioNTech ends colorectal cancer mRNA therapy trial early
Syneos Health, Inc. (SYNH) Tops Q4 EPS by 14c, Offers Guidance
February 28, 2018 6:43 AM ESTSyneos Health, Inc. (NASDAQ: SYNH) reported Q4 EPS of $0.70, $0.14 better than the analyst estimate of $0.56. Net revenue for the quarter came in at $750.5 million versus the consensus estimate of $760.38 million.
GUIDANCE:
Syneos Health, Inc. sees Q1 2018 EPS of $0.54-$0.60, versus... More
